• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Novel anthracycline analogs.

作者信息

Grandi M, Pezzoni G, Ballinari D, Capolongo L, Suarato A, Bargiotti A, Faiardi D, Spreafico F

机构信息

Farmitalia Carlo Erba Research Centre, R & D Oncology Department, Milano, Italy.

出版信息

Cancer Treat Rev. 1990 Sep;17(2-3):133-8. doi: 10.1016/0305-7372(90)90037-g.

DOI:10.1016/0305-7372(90)90037-g
PMID:2272029
Abstract
摘要

相似文献

1
Novel anthracycline analogs.新型蒽环类类似物。
Cancer Treat Rev. 1990 Sep;17(2-3):133-8. doi: 10.1016/0305-7372(90)90037-g.
2
Antitumor spectrum of a new anthracycline, (2"R)-4'-O-tetrahydropyranyladriamycin, and effect on the cellular immune response in mice.一种新型蒽环类药物（2“R）-4'-O-四氢吡喃阿霉素的抗肿瘤谱及其对小鼠细胞免疫反应的影响。
Jpn J Cancer Res. 1985 Oct;76(10):1008-20.
3
[Modulation of anthracycline resistance by reserpine in P388 leukemia cells].[利血平对P388白血病细胞阿霉素耐药性的调节作用]
Nihon Yakurigaku Zasshi. 1991 Jul;98(1):1-6. doi: 10.1254/fpj.98.1_1.
4
[Anthracycline antibiotics and their derivatives--inhibitors of topoisomerase I].[蒽环类抗生素及其衍生物——拓扑异构酶I抑制剂]
Bioorg Khim. 2008 May-Jun;34(3):430-2. doi: 10.1134/s1068162008030230.
5
Preclinical Study of Pharmacological Properties of Doxorubicin-NPh.多柔比星-NPh 的药理学性质的临床前研究。
Bull Exp Biol Med. 2020 Oct;169(6):778-782. doi: 10.1007/s10517-020-04977-5. Epub 2020 Oct 24.
6
[The cross resistance to cytostatics of leukemia P388 cells with induced resistance to doxorubicin].[对阿霉素诱导耐药的白血病P388细胞的细胞生长抑制剂交叉耐药性]
Biull Eksp Biol Med. 1993 Sep;116(9):309-11.
7
Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.钙调蛋白抑制剂三氟拉嗪可选择性增强强DNA结合抗肿瘤药物与弱DNA结合抗肿瘤药物对阿霉素耐药的P388小鼠白血病细胞的细胞毒性作用。
Biochem Biophys Res Commun. 1985 Sep 16;131(2):912-9. doi: 10.1016/0006-291x(85)91326-9.
8
[The effect of finoptin on doxorubicin accumulation in leukemia P-388 cells with induced resistance to the combination of finoptin and doxorubicin].[氟哌啶醇对白血病P-388细胞中阿霉素蓄积的影响以及对氟哌啶醇与阿霉素联合用药的诱导抗性]
Biull Eksp Biol Med. 1990 Mar;109(3):290-2.
9
[Augmentation of pirarubicin cytotoxicity by chlorpromazine in doxorubicin-resistant mouse P388 leukemia cells].[氯丙嗪增强阿霉素耐药小鼠P388白血病细胞对吡柔比星的细胞毒性作用]
Yakugaku Zasshi. 1990 Sep;110(9):678-81. doi: 10.1248/yakushi1947.110.9_678.
10
Antitumor activity of free and liposome-entrapped annamycin, a lipophilic anthracycline antibiotic with non-cross-resistance properties.游离型和脂质体包裹型阿那霉素的抗肿瘤活性，阿那霉素是一种具有非交叉耐药特性的亲脂性蒽环类抗生素。
Cancer Res. 1994 Mar 15;54(6):1479-84.

引用本文的文献

1
Engineered biosynthesis of aklanonic acid analogues.阿克拉诺酸类似物的工程化生物合成。
J Am Chem Soc. 2005 Sep 7;127(35):12254-62. doi: 10.1021/ja051429z.
2
Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases.白细胞介素2激活的自然杀伤细胞递送甲氧基吗啉基阿霉素：对荷肝转移瘤小鼠的作用
Br J Cancer. 1999 Mar;79(7-8):1067-73. doi: 10.1038/sj.bjc.6690171.
3
Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients.
甲氧基吗啉代阿霉素（FCE 23762-MMRDX）在非小细胞肺癌、肾癌及其他实体瘤患者中的广泛II期和药代动力学研究。
Br J Cancer. 1998;77(1):139-46. doi: 10.1038/bjc.1998.22.
4
Morpholinylanthracyclines: cytotoxicity and antitumor activity of differently modified derivatives.吗啉代蒽环类药物：不同修饰衍生物的细胞毒性和抗肿瘤活性
Invest New Drugs. 1996;14(2):139-46. doi: 10.1007/BF00210784.
5
L1210 cells selected for resistance to methoxymorpholinyl doxorubicin appear specifically resistant to this class of morpholinyl derivatives.选择对甲氧基吗啉基阿霉素具有抗性的L1210细胞对这类吗啉基衍生物表现出特异性抗性。
Br J Cancer. 1994 Feb;69(2):315-9. doi: 10.1038/bjc.1994.57.
6
Effects of the methoxymorpholino derivative of doxorubicin and its bioactivated form versus doxorubicin on human leukemia and lymphoma cell lines and normal bone marrow.
Cancer Chemother Pharmacol. 1993;33(1):10-6. doi: 10.1007/BF00686016.
7
Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linker.甲氧基吗啉基阿霉素的代谢转化：从DNA链断裂剂到DNA交联剂。
Br J Cancer. 1994 Jul;70(1):79-84. doi: 10.1038/bjc.1994.253.
8
Growth-inhibitory properties of novel anthracyclines in human leukemic cell lines expressing either Pgp-MDR or at-MDR.
Invest New Drugs. 1994;12(2):93-7. doi: 10.1007/BF00874437.
9
The role of methoxymorpholino anthracycline and cyanomorpholino anthracycline in a sensitive small-cell lung-cancer cell line and its multidrug-resistant but P-glycoprotein-negative and cisplatin-resistant counterparts.甲氧基吗啉代蒽环类药物和氰基吗啉代蒽环类药物在一种敏感的小细胞肺癌细胞系及其多药耐药但P-糖蛋白阴性且顺铂耐药的对应细胞系中的作用。
Cancer Chemother Pharmacol. 1995;35(4):345-8. doi: 10.1007/BF00689457.
10
In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells.FCE 23762（一种对阿霉素耐药肿瘤细胞有活性的阿霉素甲氧基吗啉基衍生物）的体内抗肿瘤活性
Br J Cancer. 1992 May;65(5):703-7. doi: 10.1038/bjc.1992.148.